1: Sun Q, Shi M, Shao W, Shi Y, Xi Y, Huang G. Tissue distribution and pulmonary
targeting studies of cefpiramide sodium-loaded liposomes. J Drug Target. 2011
Jan;19(1):49-55. doi: 10.3109/10611861003667607. Epub 2010 Mar 5. PubMed PMID:
20205530.
2: Allan JD, Eliopoulos GM, Ferraro MJ, Moellering RC Jr. Comparative in vitro
activities of cefpiramide and apalcillin individually and in combination.
Antimicrob Agents Chemother. 1985 May;27(5):782-90. PubMed PMID: 3925875; PubMed
Central PMCID: PMC180152.
3: Wang H, Yu Y, Xie X, Wang C, Zhang Y, Yuan Y, Zhang X, Liu J, Wang P, Chen M.
In-vitro antibacterial activities of cefpiramide and other broad-spectrum
antibiotics against 440 clinical isolates in China. J Infect Chemother. 2000
Jun;6(2):81-5. PubMed PMID: 11810540.
4: Guji A, Nishiya H, Aoki M, Ohyatsu I, Yamaguchi M, Tokumura Y, Sugiyama H,
Miyashita T, Ono Y, Kunii O. Glutathione S-transferases as a cefpiramide binding
protein in rat liver. Pharmacol Toxicol. 1995 Mar;76(3):212-7. PubMed PMID:
7617548.
5: Matsui H, Okuda T. Renal tubular mechanisms for excretion of cefpiramide
(SM-1652) in association with its long-lasting pharmacokinetic properties. J
Pharmacobiodyn. 1988 Feb;11(2):67-73. PubMed PMID: 3379566.
6: Fu KP, Vince T, McCloud S, Gregory FJ, Chiang ST, Hung PP. Experimental
efficacy and pharmacokinetic properties of cefpiramide, a new cephalosporin.
Drugs Exp Clin Res. 1985;11(11):787-91. PubMed PMID: 3939215.
7: Nakagawa K, Koyama M, Matsui H, Ikeda C, Yano K, Nakatsuru N, Yoshinaga K,
Noguchi T. Pharmacokinetics of cefpiramide (SM-1652) in humans. Antimicrob Agents
Chemother. 1984 Feb;25(2):221-5. PubMed PMID: 6712202; PubMed Central PMCID:
PMC185478.
8: Takikawa H, Uchida Y, Sano N, Yamanaka M. Biliary cefpiramide excretion: its
relation to biliary excretion of bile acids and sulfobromophthalein.
Pharmacology. 1995 Jun;51(1):24-32. PubMed PMID: 7568341.
9: Tamai I, Maekawa T, Tsuji A. Membrane potential-dependent and carrier-mediated
transport of cefpiramide, a cephalosporin antibiotic, in canalicular rat liver
plasma membrane vesicles. J Pharmacol Exp Ther. 1990 May;253(2):537-44. PubMed
PMID: 2338647.
10: Brogard JM, Jehl F, Blickle JF, Arnaud JP, Monteil H. Experimental and
clinical evaluation of the biliary pharmacokinetic profile of cefpiramide, a new
cephalosporin with high hepatic elimination. Drugs Exp Clin Res.
1988;14(8):519-27. PubMed PMID: 3248507.
11: Neu HC, Chin NX. The in vitro activity and beta-lactamase stability of
cefpiramide compared with other beta-lactam antibiotics. Diagn Microbiol Infect
Dis. 1985 Nov;3(6):479-88. PubMed PMID: 3877607.
12: Barry AL, Jones RN, Thornsberry C, Fuchs PC, Ayers LW, Gavan TL, Gerlach EH,
Sommers HM. Cefpiramide: comparative in-vitro activity and beta-lactamase
stability. J Antimicrob Chemother. 1985 Sep;16(3):315-25. PubMed PMID: 3877041.
13: Fu KP, Hetzel N, Hung PP, Gregory FJ. Therapeutic efficacy of cefpiramide and
cefoperazone alone and in combination with gentamicin against pseudomonal
infections in neutropenic mice. Chemotherapy. 1986;32(2):166-72. PubMed PMID:
3698725.
14: Tsuji A, Terasaki T, Takanosu K, Tamai I, Nakashima E. Uptake of
benzylpenicillin, cefpiramide and cefazolin by freshly prepared rat hepatocytes.
Evidence for a carrier-mediated transport system. Biochem Pharmacol. 1986 Jan
15;35(2):151-8. PubMed PMID: 3080003.
15: Demontes-Mainard F, Vinçon G, Labat L, Amouretti M, Necciari J, Kieffer G,
Bannwarth B. Cefpiramide kinetics and plasma protein binding in cholestasis. Br J
Clin Pharmacol. 1994 Mar;37(3):295-7. PubMed PMID: 8198940; PubMed Central PMCID:
PMC1364762.
16: Brogard JM, Blickle JF, Adloff M, Jehl F, Monteil H. [Cefpiramide, a new
cephalosporin with high hepatic elimination; experimental evaluation of its
biliary passage and disposition in the liver]. Pathol Biol (Paris). 1989
May;37(5):418-23. French. PubMed PMID: 2780097.
17: Quentin C, Noury P, Titonel M. Comparative in vitro activity of cefpiramide,
a new parenteral cephalosporin. Eur J Clin Microbiol Infect Dis. 1988
Aug;7(4):544-9. PubMed PMID: 3141169.
18: Kuleshov SE, Zabrosaev VS, Ovsiankin AV, Petrochenkova NA. [Attempt to use
cefpiramide (Tamicin) in patients with infectious destructive lung diseases].
Antibiot Khimioter. 1995 Feb;40(2):51-4. Russian. PubMed PMID: 7605144.
19: Matsui H, Okuda T. Penetration of cefpiramide and cefazolin into peritoneal
capsular fluid in rabbits. Antimicrob Agents Chemother. 1988 Jan;32(1):33-6.
PubMed PMID: 3348610; PubMed Central PMCID: PMC172093.
20: Fu KP, Hetzel N, Gregory FJ, Hung PP. Therapeutic efficacy of
cefpiramide-ciprofloxacin combination in experimental Pseudomonas infections in
neutropenic mice. J Antimicrob Chemother. 1987 Oct;20(4):541-6. PubMed PMID:
3680089.
